Evidence map›Paper›PMID 35044215›Full record

ArticleJournal of virology2022

Cindy M Spruit, Xueyong Zhu, Ilhan Tomris, María Ríos-Carrasco, Alvin X Han, Frederik Broszeit, Roosmarijn van der Woude, Kim M Bouwman, Michel M T Luu, Keita Matsuno and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. ComplexJournal of virology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Cindy M SpruitDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht Universitygrid.5477.1, Utrecht, the Netherlands.
Xueyong ZhuDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Ilhan TomrisDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht Universitygrid.5477.1, Utrecht, the Netherlands.
María Ríos-CarrascoDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht Universitygrid.5477.1, Utrecht, the Netherlands.
Alvin X HanDepartment of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Frederik BroszeitDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht Universitygrid.5477.1, Utrecht, the Netherlands.
Roosmarijn van der WoudeDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht Universitygrid.5477.1, Utrecht, the Netherlands.
Kim M BouwmanDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht Universitygrid.5477.1, Utrecht, the Netherlands.
Michel M T LuuDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht Universitygrid.5477.1, Utrecht, the Netherlands.
Keita MatsunoDivision of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido Universitygrid.39158.36, Sapporo, Japan.ORCID 0000-0002-4205-6526
Yoshihiro SakodaInternational Collaboration Unit, International Institute for Zoonosis Control, Hokkaido Universitygrid.39158.36, Sapporo, Japan.
Colin A RussellDepartment of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Ian A WilsonDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Geert-Jan BoonsDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht Universitygrid.5477.1, Utrecht, the Netherlands.
Robert P de VriesDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht Universitygrid.5477.1, Utrecht, the Netherlands.ORCID 0000-0002-1586-4464
Utrecht University · NLAmsterdam University Medical Centers · NLSapporo University · JPScripps Research Institute · USUniversity of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza A viruses (IAV) initiate infection by binding to glycans with terminal sialic acids on the cell surface. Hosts of IAV variably express two major forms of sialic acid,

Indexed as

Hemagglutinin Glycoproteins, Influenza VirusInfluenza A Virus, H7N7 SubtypeNeuraminic AcidsAnimalsHorsesHumansN-Acetylneuraminic AcidPhylogenyPolysaccharidesProtein BindingHemagglutinin Glycoproteins, Influenza VirusN-Acetylneuraminic AcidNeuraminic AcidsN-glycolylneuraminic acidPolysaccharidesglycan arrayH7hemagglutinininfluenzaNeuGcN-glycolylneuraminic acidreceptor-ligand interactionsialic acid

Identifiers

PMID35044215
PMCPMC8906439
OpenAlexW4206298370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.